Hiroaki Tanaka
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 39
- Inflammatory Biomarkers in Disease Prognosis 33
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment 16
-
- Gastric Cancer Management and Outcomes 43
- Metastasis and carcinoma case studies 28
- Cancer Research top 5%
- Immunology top 5%
- Immune Cell Function and Interaction 15
- Immunotherapy and Immune Responses 15
-
- Esophageal Cancer Research and Treatment 24
- Co-authors
- Masaichi OhiraKosei HirakawaKazuya MugurumaNaoshi KuboKatsunobu SakuraiTakahiro ToyokawaMasakazu YashiroKiyoshi Maeda
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hiroaki Tanaka
167 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 101
- Oncology 2.0k
- Gastroenterology 198
- Pulmonary and Respiratory Medicine 1.2k
- Cancer Research 522
- Immunology 672
Countries citing papers authored by Hiroaki Tanaka
This map shows the geographic impact of Hiroaki Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Tanaka more than expected).
Fields of papers citing papers by Hiroaki Tanaka
This network shows the impact of papers produced by Hiroaki Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Tanaka. The network helps show where Hiroaki Tanaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroaki Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 11 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 2 | |
| 8 | 2018 | 50 | |
| 9 | 2018 | 20 | |
| 10 | 2018 | 45 | |
| 11 | 2018 | 46 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 18 | |
| 14 | 2015 | 41 | |
| 15 | [Stage IV small cell esophageal carcinoma that responded to various chemotherapeutic regimens with relative longevity - a case report]. | 2014 | 1 |
| 16 | 2013 | 8 | |
| 17 | 2013 | 20 | |
| 18 | 2012 | 17 | |
| 19 | 2010 | 38 | |
| 20 | 1989 | 7 |
About Hiroaki Tanaka
Hiroaki Tanaka is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 172 papers that have together received 3.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (43 papers), Cancer Immunotherapy and Biomarkers (39 papers), Inflammatory Biomarkers in Disease Prognosis (33 papers), Metastasis and carcinoma case studies (28 papers), Esophageal Cancer Research and Treatment (24 papers), Gastrointestinal Tumor Research and Treatment (16 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (15 papers). The work is most often cited by research in Oncology (2.0k citations), Gastroenterology (198 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Hiroaki Tanaka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Masaichi Ohira, Kosei Hirakawa, Kazuya Muguruma, Naoshi Kubo, Katsunobu Sakurai, Takahiro Toyokawa, Masakazu Yashiro, Kiyoshi Maeda, Tatsuro Tamura and Ryosuke Amano. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.